Trial Profile
A non-randomised, multicentre, phase II clinical study of CP-4055 in chemotherapy-naive patients with metastatic malignant melanoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Elacytarabine (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 16 Oct 2005 New trial record.